Clinical Trials Logo

Eye Pain clinical trials

View clinical trials related to Eye Pain.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06085352 Completed - Ocular Pain Clinical Trials

Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure

Start date: June 26, 2023
Phase: Early Phase 1
Study type: Interventional

The goal of this clinical trial is to determine the safety, efficacy, and comfort of the investigational TetraLens bandage contact lens in patients who have undergone photorefractive keratectomy (PRK). The main question[s] it aims to answer are: - Understand benefit of managing pain following the surgical procedure - Understand the safety of the Tetralens Participants will be asked to wear theTetraLens BCL in one eye for 6 days post-operatively and: document the daily quantity of oral analgesics needed and report ocular pain and contact lens comfort. Researchers will compare the study lens in one eye to a control lens in the contralateral (other eye)

NCT ID: NCT05832996 Completed - Clinical trials for Ocular Surface Disease

Cool vs Room-temperature Artificial Tears

Start date: March 1, 2022
Phase: Phase 4
Study type: Interventional

Background and Objective: To evaluate the efficacy of cooled versus room temperature artificial tears in reducing post intravitreal injection (IVI) ocular discomfort. Patients and Methods: Patients receiving IVI were randomized to either cooled or room temperature tears intervention groups. Both groups rated their ocular discomfort following IVI before intervention and again after administration of cooled or room temperature tears.

NCT ID: NCT04648085 Completed - Dry Eye Clinical Trials

Effect of Trigeminal Nerve Stimulation on Corneal Nerves and Chronic Ocular Pain

Start date: February 3, 2021
Phase: N/A
Study type: Interventional

Individuals with dry eye tend to present with ocular pain which persists despite the use of topical treatment. This could be secondary to somatosensory impairment attributable to neuropathic pain. The purpose of this study is to evaluate the effect of trigeminal nerve stimulation (TNS) on corneal nerves and chronic ocular pain in patients with dry eye.

NCT ID: NCT03063489 Completed - Eye Pain Clinical Trials

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability

Start date: February 2015
Phase: Phase 1
Study type: Interventional

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of Loteprednol Etabonate Ophthalmic Gel, in Normal Healthy Volunteers

NCT ID: NCT02961062 Completed - Clinical trials for Postoperative Ocular Pain After PRK Surgery

Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery

Start date: December 1, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if SAF312 eye drops have an adequate safety and efficacy profile to justify further clinical development for the treatment of ocular pain associated with corneal epithelial defect such as after photorefractive keratectomy (PRK) surgery

NCT ID: NCT02455999 Completed - Dry Eye Syndrome Clinical Trials

Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain

Start date: June 2015
Phase: Phase 2
Study type: Interventional

The aim of this pilot study is to compare the analgesic effect of two strengths of SYL1001 eye drops versus placebo in patients with ocular pain associated with Dry Eye Syndrome. General and local tolerability are also evaluated.

NCT ID: NCT01776658 Completed - Dry Eye Syndrome Clinical Trials

Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain

Start date: November 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this pilot study is to compare the analgesic effect of SYL1001 versus placebo in patients with ocular pain associated with Dry Eye Syndrome. General and local tolerability are also evaluated.

NCT ID: NCT01438281 Completed - Dry Eye Clinical Trials

Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers

Start date: July 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether SYL1001 is safe for the prevention and treatment of ocular pain and dry eye syndrome.